F
$ Value
$59K
Shares
1,924
Price
$31
Filed
Jun 2
Insider
Name
snyderman nancy lynn MD
Title
—
CIK
0001675198
Roles
Director
Transaction Details
Transaction Date
2025-05-31
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
10,728
Footnotes
Each restricted stock unit represents a contingent right to receive one ordinary share. | Shares are held by the Nancy Lynn Snyderman Revocable Trust (the "Snyderman Trust"), of which the reporting person is both the sole trustee and sole beneficiary. | This award is fully vested in accordance with its terms.
Filing Info
snyderman nancy lynn MD's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-05-31 | ALKS | M | — |
| 2025-05-31 | ALKS | F | $59K |
| 2025-05-31 | ALKS | M | — |
| 2025-05-21 | ALKS | A | $0 |
| 2025-05-21 | ALKS | A | $0 |
| 2025-05-14 | LYRA | A | $0 |
Other Insiders at ALKS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Lurker Nancy | — | — | 2026-04-11 |
|
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
|
— | $70K | 2026-04-06 |
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
|
— | $320K | 2026-04-01 |